Back to top

Image: Bigstock

Is Trending Stock Medical Properties Trust, Inc. (MPW) a Buy Now?

Read MoreHide Full Article

Medical Properties (MPW - Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Over the past month, shares of this health care real estate investment trust have returned +2.5%, compared to the Zacks S&P 500 composite's +0.4% change. During this period, the Zacks REIT and Equity Trust - Other industry, which Medical Properties falls in, has lost 3.1%. The key question now is: What could be the stock's future direction?

Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.

Earnings Estimate Revisions

Rather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.

Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.

For the current quarter, Medical Properties is expected to post earnings of $0.40 per share, indicating a change of -13% from the year-ago quarter. The Zacks Consensus Estimate has changed -3.2% over the last 30 days.

For the current fiscal year, the consensus earnings estimate of $1.59 points to a change of -12.6% from the prior year. Over the last 30 days, this estimate has changed -0.7%.

For the next fiscal year, the consensus earnings estimate of $1.58 indicates a change of -0.3% from what Medical Properties is expected to report a year ago. Over the past month, the estimate has changed -0.1%.

Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Medical Properties is rated Zacks Rank #4 (Sell).

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

12-month consensus EPS estimate for MPW _12MonthEPSChartUrl

Projected Revenue Growth

While earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.

In the case of Medical Properties, the consensus sales estimate of $369.2 million for the current quarter points to a year-over-year change of -7.8%. The $1.45 billion and $1.45 billion estimates for the current and next fiscal years indicate changes of -5.9% and -0.1%, respectively.

Last Reported Results and Surprise History

Medical Properties reported revenues of $350.21 million in the last reported quarter, representing a year-over-year change of -14.5%. EPS of $0.05 for the same period compares with $0.47 a year ago.

Compared to the Zacks Consensus Estimate of $351.97 million, the reported revenues represent a surprise of -0.5%. The EPS surprise was 0%.

Over the last four quarters, the company surpassed EPS estimates just once. The company topped consensus revenue estimates two times over this period.

Valuation

Without considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.

While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S) and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.

As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Medical Properties is graded B on this front, indicating that it is trading at a discount to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

Bottom Line

The facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Medical Properties. However, its Zacks Rank #4 does suggest that it may underperform the broader market in the near term.


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Medical Properties Trust, Inc. (MPW) - free report >>

Published in